Forward to a friend |
Subscribe | The Record Archive | Contacts | bcbsm.com | Print this article
|
November 2024
2025 coverage change for GLP-1 drugs to treat obesityBeginning Jan. 1, 2025, or on the group’s 2025 health coverage renewal date, Blue Cross Blue Shield of Michigan and Blue Care Network will no longer cover prescriptions for glucagon-like peptide-agonist drugs used for weight loss, including Saxenda®, Wegovy® and Zepbound®. This change applies to Blue Cross and BCN commercial members of fully insured large groups with a prescription drug plan. If members decide to use these medications for weight loss in 2025 after their group’s renewal date, they’ll be responsible for the full cost. Affected members have already gotten letters notifying them about the change coming and will receive another letter before this change. Some self-funded groups also have removed coverage for these medications. Additional information Members can visit the websites for Saxenda, Wegovy and Zepbound to determine if they offer discount coupons. These medications may also be offered at a discount through GoodRx. |
|
No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.
|